Comparative Clinical Study Between Virtual Reality Hypnosis and Nitrous Oxide Inhalation for Dental Anxie

Not Applicable

• Conditions: Dental Anxiety
• Interventions: Device: Dispositif de RV - HYPNO VR; Drug: Nitrous Oxide inhalation

• Registration Number: NCT05167331
• Lead Sponsor: University Hospital, Strasbourg, France

Brief Summary

The vicious circle of dental anxiety impacts major aspects of a child's quality of life. Hypnosis using distraction is one of the most common non-pharmalogical techniques in behavior and pain management in pediatric dentistry. Its value over traditional pharmalogical sedation is undeniable. This clinical study examines the application of hypnosis delivered through immersive virtual reality (VR) for anxious children ongoing dental procedures. The investigators will explore whether VR is as effective on pain and anxiety relief as a pharmacological sedation with inhalation of nitrous oxide.

Detailed Description

The working hypothesis of this study is that hypnosis through virtual reality can reduce children's anxiety as well as their pain level during dental care with an efficiency and tolerance at least similar to nitrous oxide inhalation. Specifically, the statistical analyses will be based on an assumption of non-inferiority of VR compared to the pharmacological technique of nitrous oxide sedation.

Each patient (aged from 6 to 10) attended for two visits in order to benefit of 2 similar conservative dental treatments on primary molars.

Everyone was randomly allocated to receive hypnosis through virtual reality or nitrous oxide/oxygen titrated to 50%/50% at the first visit, the alternative being used at the second visit. This randomization helps avoid any experimental bias related to a first positive or negative experience, each patient being its own control.

Vital signs and a video of the child's behavior are recorded for an external examinator. The video shows the child's body response as an indicator for his anxiety level through the procedures. The child's face doesn't appear on the video in order to reduce risks of bias.

Study Timeline

• Study First Submitted: 2021-11-25
• Study First Submitted QC: 2021-12-07
• Study First Posted: 2021-12-22
• Status Verified: 2022-02
• Study Start: 2022-02
• Primary Completion: 2022-02
• Last Update Submitted: 2022-02-01
• Last Update Posted: 2022-02-17
• Study Completion: 2023-03

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Virtual Reality	Dispositif de RV - HYPNO VR	* (T1) after fitting the headset to the child's face, the assistant starts the VR program chosen by the child. * (T2) Five minutes after induction, local anesthesia with the QUICKSLEEPER device is performed. The injection of a cartridge of anesthetic Articaïne SEPTANEST 1/200 000 is administered intraosseously. * (T3) After placing the rubber dam, the investigator performs restorative +/- endodontic care of the selected temporary molar. * (T4) Once the treatment is finished, the sedation is stopped and the patient rests in the chair for 5 minutes. * (T5) As soon as the investigator considers that the child is back to normal state, he can leave the office with his parents.
Nitrous oxide sedation	Nitrous Oxide inhalation	* (T1) With the nitrous oxide/oxygen inhalation system titrated to 50%/50% whose flow rate is adapted to the child's respiratory flow. The assistant is responsible for controlling the sedation. Verbal encouragement is always present to reassure the child. * (T2) Five minutes after induction, local anesthesia with the QUICKSLEEPER device is performed. The injection of a cartridge of anesthetic Articaïne SEPTANEST 1/200 000 is administered intraosseously. * (T3) After placing the rubber dam, the investigator performs restorative +/- endodontic care of the selected temporary molar. * (T4) Once the treatment is finished, the sedation is stopped and the patient rests in the chair for 5 minutes. * (T5) As soon as the investigator considers that the child is back to normal state, he can leave the office with his parents.

Primary Outcome Measures

Name	Time	Method
Anxiolysis assessed by a standardized hetero-assessment scale (Venham Modified Scale)	5 weeks	Child behavior can be assessed using the Veerkamp Modified Venham Scale (VMS). This is a scale from 0 (completely calm and relaxed patient) to 5 (distressed patient, completely disconnected). Several parameters are taken into account in this scale such as: the child's movements, crying or screaming, the possibility or not of performing the treatment. The authors have found this scale to be a reliable, easy-to-use and reproducible instrument when it comes to assessing children's behavior.; This outcome measure is assessed by an external examinator with the video recording the procedures.

Secondary Outcome Measures

Name	Time	Method
Assessment of analgesia with VR	5 weeks	Assessment of analgesia using self-assessed pain levels on standardized age-appropriate scales (VAS: Visual Analogue Scale)
Assessment of children's tolerance levels to VR and pharmacological technique.	5 weeks	Assessment of tolerance and response to VR-MEOPA using the number and proportion of patients intolerant to VR and to pharmacological techniques. Evaluate the proportion of VR or MEOPA sessions interrupted (lack of therapeutic continuity). Any patient who has interrupted VR more than once or who refused VR during the procedure is considered intolerant of VR.
Assessment of the impact of the child's temperament on his acceptance of nitrous oxide and RV sedations using a questionnaire and a temperament scale	The parents answer to the questionnaire on the first visit during inclusion.	To assess the child's temperament dimensions, parents answer to an Emotionality, Activity and Sociability questionnaire with the help of an investigator before the treatment session. The AES questionnaire had already been validated in France in children aged from 6 to 12 years-old in 2002. The AES questionnaire is a questionnaire containing 25 items based on a model of three main dimensions: Emotionality, Activity and Sociability. Each item has a Likert-type scale ranging from 1 (extremely false, not at all corresponding to my child) to 5 (extremely fair, corresponding to my child).

Trial Locations

Locations (1)

Les Hôpitaux Universitaires de Strasbourg; 🇫🇷 Strasbourg, France